| 
 
 
	
		|  |  
	
	
		
	
	
	
		|  10-09-2008, 09:55 AM | #1 |  
	| Senior Member 
				 
				Join Date: Mar 2006 
					Posts: 4,780
				 
		 
		 
		
		 
		
		
	
		
	
	 | 
				
				bisphenol A linked to chemotherapy resistance
			 
 Bisphenol A Linked to Chemotherapy Resistance 
[University of Cincinnati Medical Center] 
CINCINNATI—Exposure to bisphenol A (BPA) may reduce the effectiveness of chemotherapy treatments, say University of Cincinnati (UC) scientists. 
The research study, led by UC's Nira Ben-Jonathan, PhD, says that BPA—a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans—actually induces a group of proteins that protect cancer cells from the toxic effects of chemotherapy. 
The findings are reported in the journal Environmental Health Perspectives and appear online Oct. 8, 2008, ahead of print. 
"Resistance to chemotherapy is a major problem for cancer patients, especially those with advanced or metastatic disease," says Ben-Jonathan, a professor of cancer and cell biology at UC who has studied BPA for more than 10 years. "Finding out what contributes to that resistance can give us an idea of what to target in order to make chemotherapy as effective as possible." 
Researchers have suspected that BPA could play a role in cancer because of the chemical's structural similarities to a cancer-promoting compound called diethylstilbestrol (DES). But Ben-Jonathan's team found that BPA isn't exactly mimicking the action of DES. 
"BPA does not increase cancer cell proliferation like DES does," she says. "It's actually acting by protecting existing cancer cells from dying in response to anti-cancer drugs, making chemotherapy significantly less effective." 
Ben-Jonathan's team studied human breast cancer cells, subjecting them to low levels of BPA consistent with levels found in the blood of human adults. The team found that BPA is acting in cancer cells similar to the way estrogen does—by inducing proteins that protect the cells from chemotherapy agents. 
Estrogen's protein-inducing action has been previously linked to chemotherapy resistance, but researchers have been unable to explain why such resistance still occurs in certain patients with less estrogen. Ben-Jonathan says her team's research has important implications for this subgroup of patients. 
"Patients with less circulating estrogen—post-menopausal women, for example—can also suffer from chemotherapy resistance," she says. "Linking BPA to this problem gives us one more avenue to explore in terms of preventing chemotherapy resistance." 
"These data," study authors write, "provide considerable support to the accumulating evidence that BPA is hazardous to human health." 
Coauthors include Elizabeth LaPensee, Sejal Fox and Traci Tuttle. 
The study was funded by grants from the National Institutes of Health, the Department of Defense and the Susan G. Komen Breast Cancer Foundation.
http://www.ehponline.org/members/2008/11788/11788.pdf 
 Bisphenol A at Low Nanomolar Doses Confers  
Chemoresistance in Estrogen Receptor Alpha Positive and Negative Breast Cancer Cells  
[Environmental Health Perspectives] 
Background: Resistance to chemotherapy is a major problem facing breast cancer patients, and identifying potential contributors to chemoresistance is a critical area of research. Bisphenol A (BPA) has long been suspected to promote carcinogenesis, but the high doses of BPA used in many studies generated conflicting results. In addition, the mechanism by which BPA exerts its biological actions is unclear. While estrogen has been shown to antagonize anti-cancer drugs, the role of BPA in chemoresistance has not been examined. 
Objective: The objective was to determine whether BPA at low nanomolar concentrations opposes the action of doxorubicin, cisplatin and vinblastine in the ERα positive T47D and the ERα negative MDA-MB-468 breast cancer cells. 
Methods: The responsiveness of cells to anti-cancer drugs and BPA was determined by the MTT cytotoxicity assay. Specific ERα and ERβ inhibitors and real-time PCR were used to identify potential receptor(s) that mediate the actions of BPA. Expression of anti-apoptotic proteins was assessed by Western blotting. 
Results: BPA antagonizes the cytotoxicity of multiple chemotherapeutic agents in both ERα positive and negative breast cancer cells independent of the classical ERs. Both cell types express alternative ER receptors, including GRP30 and members of the estrogen related receptor (ERR) family. Increased expression of anti-apoptotic proteins is a potential mechanism by which BPA exerts its anti-cytotoxic effects. 
Conclusions: BPA at environmentally relevant doses reduces the efficacy of chemotherapeutic agents. These data provide considerable support to the accumulating evidence that BPA is hazardous to human health. |  
	|   |   |  
	
		
	
	
	
		|  10-09-2008, 10:18 AM | #2 |  
	| Senior Member 
				 
				Join Date: Oct 2005 
					Posts: 3,519
				 
		 
		 
		
		 
		
		
	
		
	
	 | Wow! - Time to buy yourselves a stainless steel travel cup and fill it with your home-filtered tap water. Just say no to plastic water bottles... either that or only buy bottled water in glass. From time to time, I find cases of glass bottled water on a great sale, and I buy it up when I do, but usually it's too expensive.
 And whatever you do, don't drink out of plastic water bottles after they have been sitting in the sun in a hot car!
 
				__________________Brenda
 
 NOV 2012 - 9 yr anniversary
 JULY 2012 - 7 yr anniversary stage IV (of 50...)
 
 Nov'03~ dX stage 2B
 Dec'03~ Rt side mastectomy, Her2+, ER/PR+, 10 nodes out, one node positive
 Jan'04~ Taxotere/Adria/Cytoxan x 6, NED, no Rads, Tamox. 1 year, Arimadex 3 mo., NED 14 mo.
 Sept'05~ micro mets lungs/chest nodes/underarm node, Switched to Aromasin, T/C/H x 7, NED 6 months - Herceptin only
 Aug'06~ micro mets chest nodes, & bone spot @ C3 neck, Added Taxol to Herceptin
 Feb'07~ Genetic testing, BRCA 1&2 neg
 Apr'07~ MRI - two 9mm brain mets & 5 punctates, new left chest met, & small increase of bone spot C3 neck, Stopped Aromasin
 May'07~ Started Tykerb/Xeloda, no WBR for now
 June'07~ MRI  - stable brain mets, no new mets, 9mm spots less enhanced, CA15.3 down 45.5 to 9.3 in 10 wks, Ty/Xel working magic!
 Aug'07~ MRI - brain mets shrunk half, NO NEW BRAIN METS!!, TMs stable @ 9.2
 Oct'07~ PET/CT & MRI show NED
 Apr'08~ scans still show NED in the head, small bone spot on right iliac crest (rear pelvic bone)
 Sept'08~ MRI shows activity in brain mets, completed 5 fractions/5 consecutive days of IMRT to zap the pesky buggers
 Oct'08~ dropped Xeloda, switched to tri-weekly Herceptin in combo with Tykerb, extend to tri-monthly Zometa infusion
 Dec'08~ Brain MRI- 4 spots reduced to punctate size, large spot shrunk by 3mm, CT of torso clear/pelvis spot stable
 June'09~ new 3-4mm left cerrebellar spot zapped with IMRT targeted rads
 Sept'09~ new 6mm & 1 cm spots in pituitary/optic chiasm area. Rx= 25 days of 3D conformal fractionated targeted IMRT to the tumors.
 Oct'09~ 25 days of low dose 3D conformal fractionated targeted IMRT to the bone mets spot on rt. iliac crest that have been watching for 2 years. Added daily Aromasin back into treatment regimen.
 Apr'10~ Brain MRI clear! But, see new small spot on adrenal gland. Change from Aromasin back to Tamoxifen.
 June'10~ Tumor markers (CA15.3) dropped from 37 to 23 after one month on Tamoxifen. Continue to monitor adrenal gland spot. Remain on Tykerb/Herceptin/Tamoxifen.
 Nov'10~ Radiate positive mediastinal node that was pressing on recurrent laryngeal nerve, causing paralyzed larynx and a funny voice.
 Jan'11~ MRI shows possible activity or perhaps just scar tissue/necrotic increase on 3 previously treated brain spots and a pituitary spot. 5 days of IMRT on 4 spots.
 Feb'11~ Enrolled in T-DM1 EAP in Denver, first treatment March 25, 2011.
 Mar'11~ Finally started T-DM1 EAP in Denver at Rocky Mountain Cancer Center/Rose on Mar. 25... hallelujah.
 
 "I would rather be anecdotally alive than statistically dead."
 |  
	|   |   |  
	
		
	
	
	
		|  10-09-2008, 10:23 AM | #3 |  
	| Senior Member 
				 
				Join Date: Feb 2008 Location: South East Wisconsin 
					Posts: 3,431
				 
		 
		 
		
		 
		
		
	
		
	
	 | Ok..so orange juice in a plastic bottle is a double whammy. Do foam cups, like ones in hospitals, have this issue? |  
	|   |   |  
	
		
	
	
	
		|  10-09-2008, 08:27 PM | #4 |  
	| Senior Member 
				 
				Join Date: Oct 2005 
					Posts: 476
				 
		 
		 
		
		 
		
		
	
		
	
	 | Bisphenol A is a component chemical used in the synthesis of polycarbonate.  Polycarbonate is a class of polymer that are impact resistant and generally unbreakable.  It lends itself in many applications where breakage must be avoided.  Polyethylene, polypropylene and polystyrene are used for making low cost white cups. 
				__________________Ann
 
 Stage 1 dx Sept 05
 ER/PR positive HER2 +++ Grade 3
 Invasive carcinoma 1 cm, no node involvement
 Mastec Sept 05
 Annual scans all negative, Oct 06
 Postmenopause. Arimidex only since Sept 06, bone or muscle ache after 3 month
 Off Arimidex, change to Femara 1/12-07, ache stopped
 Sept 07 all tests negative, pass 2 year mark
 Feb 08 continue doing well.
 Sep 09 four year NED still on Femara.
 |  
	|   |   |  
	
		
	
	
	
		|  10-13-2008, 06:50 PM | #5 |  
	| Senior Member 
				 
				Join Date: Jun 2006 
					Posts: 153
				 
		 
		 
		
		 
		
		
	
		
	
	 | Ok so why are we surprised!  This has been a continuing issue, but I was unaware that it lined my canned food.  Does this mean it is in the coatings of paper containers like milk? 
				__________________
 
 |  
	|   |   |  
	
		
	
	
	
		|  10-30-2008, 01:41 PM | #6 |  
	| Senior Member 
				 
				Join Date: Feb 2008 Location: South East Wisconsin 
					Posts: 3,431
				 
		 
		 
		
		 
		
		
	
		
	
	 | Panel Criticizes FDA Bisphenol A Report
 	    	   	             	from WebMD  — a health information Web site for patients
 	   	   	  
 	   	   	   	   	  	Miranda Hitti 
October 30, 2008 — The controversy over the plastic chemical bisphenol A is heating back up, with a panel of scientists criticizing an FDA draft report on bisphenol A safety. 
  Bisphenol A, also called BPA, is a chemical found in polycarbonate plastic -- including some water bottles and baby bottles -- and in the lining of canned goods. 
  Some research, mostly done on animals, suggests possible health risks from bisphenol A exposure, especially early in life. But an FDA draft report says bisphenol A is safe at typical exposure levels from food and drink. 
  Now, an independent subcommittee has reviewed the FDA draft report, at the FDA's request, and has posted these criticisms:
   Removing Bisphenol A From Baby Bottles?Some studies were excluded without enough explanation.Uncertainty in bisphenol A research wasn't mentioned enough.The FDA's margins of safety for bisphenol A are "inadequate."More attention should have been paid to infants' exposure to bisphenol A.
 
  The American Chemistry Council, a plastics industry trade group, issued a statement about the review of the draft report. 
  In that statement, the council pledges to abide by whatever the FDA decides about bisphenol A. 
  "If the [FDA] determines that existing margins of safety are insufficient in infant applications, our member companies that manufacture BPA will put processes in place to promptly phase out the use of materials containing BPA in baby bottles and infant formula packaging," the council states. 
  The Natural Resources Defense Council (NRDC), a nonprofit group that wants bisphenol A banned in food containers, also issued a statement about the subcommittee's review. 
  "The FDA has consistently ignored science and sound policy, putting corporate interests ahead of public protection ... it's time for the FDA to protect infants and pregnant women," says NRDC reproductive biologist Sarah Janssen, MD, PHD.
  FDA Responds 
  The scientific panel has raised "important questions," states an FDA news release. The FDA isn't brushing off those questions and calls for more research. 
  Meanwhile, the FDA hasn't changed its standards for bisphenol A safety -- or its advice to consumers. 
  "Consumers should know that, based on all available evidence, the present consensus among regulatory agencies in the United States, Canada, Europe, and Japan is that current levels of exposure to BPA through food packaging do not pose an immediate health risk to the general population, including infants and babies," the FDA states. 
  Last week, the Canadian government said it would ban bisphenol A in baby bottles. The FDA points out that that action was taken "out of an abundance of caution," and that Canadian scientists haven't found any proof of harm to babies with typical exposure to bisphenol A. 
  Here's where the FDA's draft report stands:
   It's already been discussed at a public meeting.It's gone through peer review -- that's the review by independent scientists.Next, an FDA advisory committee takes the topic up on Oct. 31.
   Those are steps toward the FDA's final report on bisphenol A -- and there is no deadline for that.
  SOURCES:
  FDA Science Board Subcommittee on BIsphenol A: "Scientific Peer-Review of the Draft Assessment of BIsphenol A for Use in Food Contact Applications."
  Statement, American Chemistry Council.
  News release, Natural Resources Defense Council. |  
	|   |   |  
	
		
	
	
	
		|  10-30-2008, 03:11 PM | #7 |  
	| Member 
				 
				Join Date: Oct 2008 Location: MN 
					Posts: 12
				 
		 
		 
		
		 
		
		
	
		
	
	 | 
				
				Other "No-No"s During Chemo?
			 
 Is anyone aware of a list anyone has put together of the things to avoid during chemo that could diminish its effectiveness (e.g., mega-antioxidants, BPA, etc.)?  Seems like a da*n shame to go through all this chemo only to be foiled unknowingly by something easily avoided! |  
	|   |   |  
	
		
	
	
	
		|  10-30-2008, 07:19 PM | #8 |  
	| Senior Member 
				 
				Join Date: Nov 2004 Location: Misty woods  of WA State 
					Posts: 4,128
				 
		 
		 
		
		 
		
		
	
		
	
	 | "The research study, led by UC's Nira Ben-Jonathan, PhD, says that BPA—a man-made chemical found in a number of plastic products, including drinking bottles and the lining of food cans—actually induces a group of proteins that protect cancer cells from the toxic effects of chemotherapy."
 This has been suspected as long as I have been fighting cancer - going on 9 years.  We buy very little in cans anyway - tuna now comes in foil packs and soups in boxes.
 
 I even have bottles to transfer things like salad dressings into.  Still is hard to give up some things that have been packed in glass that are in plastic now. Mustard and mayo for instance.
 
 Just have to keep thinking when we shop!
 
				__________________"When I hear music, I fear no danger. I am invulnerable. I see no foe. I am related to the earliest times, and to the latest." H.D. Thoreau
 Live in the moment.
 
 MY STORY SO FAR ~~~~
 Found suspicious lump 9/2000
 Lumpectomy, then node dissection and port placement
 Stage IIB, 8 pos nodes of 18, Grade 3, ER & PR -
 Adriamycin 12 weekly, taxotere 4 rounds
 36 rads - very little burning
 3 mos after rads liver full of tumors, Stage IV Jan 2002, one spot on sternum
 Weekly Taxol, Navelbine, Herceptin for 27 rounds to NED!
 2003 & 2004 no active disease - 3 weekly Herceptin + Zometa
 Jan 2005 two mets to brain - Gamma Knife on Jan 18
 All clear until treated cerebellum spot showing activity on Jan 2006 brain MRI & brain PET
 Brain surgery on Feb 9, 2006 - no cancer, 100% radiation necrosis - tumor was still dying
 Continue as NED while on Herceptin & quarterly Zometa
 Fall-2006 - off Zometa - watching one small brain spot (scar?)
 2007 - spot/scar in brain stable - finished anticoagulation therapy for clot along my port-a-catheter - 3 angioplasties to unblock vena cava
 2008 - Brain and body still NED! Port removed and scans in Dec.
 Dec 2008 - stop Herceptin - Vaccine Trial at U of W begun in Oct. of 2011
 STILL NED everywhere in Feb 2014 - on wing & prayer
 7/14 - Started twice yearly Zometa for my bones
 Jan. 2015 checkup still shows NED
 2015 Neuropathy in feet - otherwise all OK - still NED.
 Same news for 2016 and all of 2017.
 Nov of 2017 - had small skin cancer removed from my face. Will have Zometa end of Jan. 2018.
 |  
	|   |   |  
	
		
	
	
	
	
	| 
	|  Posting Rules |  
	| 
		
		You may not post new threads You may not post replies You may not post attachments You may not edit your posts 
 HTML code is Off 
 |  |  |  All times are GMT -7. The time now is 07:06 PM. |